Liu Zhijia, Xu Guangrui, Wang Chaonan, Li Chunyang, Yao Ping
State Key Laboratory of Molecular Engineering of Polymers, Collaborative Innovation Centre of Polymers and Polymer Composite Materials, Department of Macromolecular Science, Fudan University, Shanghai, 200433, China.
State Key Laboratory of Molecular Engineering of Polymers, Collaborative Innovation Centre of Polymers and Polymer Composite Materials, Department of Macromolecular Science, Fudan University, Shanghai, 200433, China.
Int J Pharm. 2017 Sep 15;530(1-2):53-62. doi: 10.1016/j.ijpharm.2017.07.063. Epub 2017 Jul 21.
In this study, glycol chitosan-Pluronic F127 conjugate (GC-PF127), produced by an amidation reaction between terminal-carboxylated PF127 and glycol chitosan (GC), was used to prepare doxorubicin (DOX)-loaded micelles. The DOX/GC-PF127 micelles produced at optimal conditions had sizes of about 150nm and pH-sensitive surface charges. DOX/GC-PF127 hydrogel formed after addition of α-cyclodextrin into DOX/GC-PF127 micelle solution. The hydrogel had good shear-responsive, injectable and rapid recovery properties. In vitro release experiment confirmed that the hydrogel could sustainedly release DOX/GC-PF127 micelles via the dissociation of the hydrogel. After peritumoral injection into H22 tumor-bearing mice, the hydrogel could greatly increase DOX accumulation in tumor tissue and synchronously avoid DOX accumulation in normal tissues including heart. At similar total DOX dose administrated, the tumors of free DOX treatment group grew slowly after thrice intravenous injections, the tumors of the micelle group did not grow after twice intravenous injections, and the tumors of the hydrogel group disappeared almost after once peritumoral injection. This study demonstrates that injectable DOX/GC-PF127 hydrogel, which can sustainedly release DOX-loaded micelles with tumor-targeting function, is a promising system for local tumor chemotherapy.
在本研究中,通过末端羧基化的PF127与乙二醇壳聚糖(GC)之间的酰胺化反应制备的乙二醇壳聚糖 - 普朗尼克F127共轭物(GC - PF127)用于制备载有阿霉素(DOX)的胶束。在最佳条件下制备的DOX/GC - PF127胶束尺寸约为150nm,且具有pH敏感的表面电荷。向DOX/GC - PF127胶束溶液中加入α-环糊精后形成DOX/GC - PF127水凝胶。该水凝胶具有良好的剪切响应性、可注射性和快速恢复性能。体外释放实验证实,水凝胶可通过水凝胶的解离持续释放DOX/GC - PF127胶束。向荷H22肿瘤小鼠瘤周注射后,水凝胶可显著增加肿瘤组织中DOX的蓄积,同时避免DOX在包括心脏在内的正常组织中蓄积。在给予相似总DOX剂量的情况下,游离DOX治疗组经三次静脉注射后肿瘤生长缓慢,胶束组经两次静脉注射后肿瘤不再生长,而水凝胶组经一次瘤周注射后肿瘤几乎消失。本研究表明,可注射的DOX/GC - PF127水凝胶能够持续释放具有肿瘤靶向功能的载DOX胶束,是一种有前景的局部肿瘤化疗体系。